Evidence map›Paper›PMID 27217553›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Osmoregulatory inositol transporter SMIT1 modulates electrical activity by adjusting PI(4,5)P2 levels.

Gucan Dai, Haijie Yu, Martin Kruse, Alexis Traynor-Kaplan, Bertil Hille

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Identification of Sodium/Myo-Inositol Transporter 1 as a Major Determinant of Arterial Contractility.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Cell-specific isotope labeling identifiesbioRxiv : the preprint server for biology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gucan DaiDepartment of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195;
Haijie YuDepartment of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195;
Martin KruseDepartment of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195;ORCID 0000-0003-4301-8385
Alexis Traynor-KaplanATK Innovation Analytics & Discovery, North Bend, WA 98045; Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, WA 98195.
Bertil HilleDepartment of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195; hille@uw.edu.ORCID 0000-0002-7266-1671
University of Washington · US

Funding

Molecular Properties of Ionic Permeability in NerveR37NS008174 · NINDS · UNIVERSITY OF WASHINGTON · PI HILLE, BERTIL · 2013 to 2019
$3.8M
NINDS NIH HHS R37 NS008174
6 · The paper itself

Abstract

Myo-inositol is an important cellular osmolyte in autoregulation of cell volume and fluid balance, particularly for mammalian brain and kidney cells. We find it also regulates excitability. Myo-inositol is the precursor of phosphoinositides, key signaling lipids including phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]. However, whether myo-inositol accumulation during osmoregulation affects signaling and excitability has not been fully explored. We found that overexpression of the Na(+)/myo-inositol cotransporter (SMIT1) and myo-inositol supplementation enlarged intracellular PI(4,5)P2 pools, modulated several PI(4,5)P2-dependent ion channels including KCNQ2/3 channels, and attenuated the action potential firing of superior cervical ganglion neurons. Further experiments using the rapamycin-recruitable phosphatase Sac1 to hydrolyze PI(4)P and the P4M probe to visualize PI(4)P suggested that PI(4)P levels increased after myo-inositol supplementation with SMIT1 expression. Elevated relative levels of PIP and PIP2 were directly confirmed using mass spectrometry. Inositol trisphosphate production and release of calcium from intracellular stores also were augmented after myo-inositol supplementation. Finally, we found that treatment with a hypertonic solution mimicked the effect we observed with SMIT1 overexpression, whereas silencing tonicity-responsive enhancer binding protein prevented these effects. These results show that ion channel function and cellular excitability are under regulation by several "physiological" manipulations that alter the PI(4,5)P2 setpoint. We demonstrate a previously unrecognized linkage between extracellular osmotic changes and the electrical properties of excitable cells.

Indexed as

Action PotentialsCalcium SignalingCell LineG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHeat-Shock ProteinsHEK293 CellsHumansInositolKCNQ2 Potassium ChannelKCNQ3 Potassium ChannelNeuronsOsmoregulationPhosphatidylinositol 4,5-DiphosphateProtein Serine-Threonine KinasesRecombinant ProteinsSuperior Cervical GanglionG Protein-Coupled Inwardly-Rectifying Potassium ChannelsHeat-Shock ProteinsInositolKCNJ6 protein, humanKCNQ2 Potassium ChannelKCNQ2 protein, humanKCNQ3 Potassium ChannelKCNQ3 protein, humanNFAT5 protein, humanPhosphatidylinositol 4,5-DiphosphateProtein Serine-Threonine KinasesRecombinant ProteinsSLC5A3 protein, humanSymportersTranscription FactorsTRPM7 protein, humanTRPM Cation Channelsion channelsmyo-inositolphosphoinositidePIP2SMIT1

Identifiers

PMID27217553
PMCPMC4988571
OpenAlexW2405174010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.